Uremic cardiomyopathy: An underdiagnosed disease

83Citations
Citations of this article
119Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Uremic cardiomyopathy is responsible for high morbidity and mortality rates among patients with chronic kidney disease (CKD) or end-stage renal disease (ESRD); however, the early implementation of hemodialysis may halt its progression. Nonconventional hemodialysis, such as frequent hemodialysis, appears to have an advantage over conventional hemodialysis. Kidney transplantation has been shown to reverse uremic cardiomyopathy and to confer a significant survival advantage over hemodialysis. Targeting future therapies at the underlying cellular mechanisms of uremic cardiomyopathy may finally start to reduce the burden of uremic cardiomyopathy in the CKD and ESRD population. © 2013 Wiley Periodicals, Inc.

References Powered by Scopus

907Citations
113Readers

This article is free to access.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Alhaj, E., Alhaj, N., Rahman, I., Niazi, T. O., Berkowitz, R., & Klapholz, M. (2013, July). Uremic cardiomyopathy: An underdiagnosed disease. Congestive Heart Failure. https://doi.org/10.1111/chf.12030

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 45

71%

Researcher 10

16%

Professor / Associate Prof. 5

8%

Lecturer / Post doc 3

5%

Readers' Discipline

Tooltip

Medicine and Dentistry 60

81%

Agricultural and Biological Sciences 8

11%

Sports and Recreations 3

4%

Engineering 3

4%

Article Metrics

Tooltip
Mentions
Blog Mentions: 1
Social Media
Shares, Likes & Comments: 7

Save time finding and organizing research with Mendeley

Sign up for free